Beranda › Kanker Payudara › New Jersey › Clifton
Uji klinis Kanker Payudara di Clifton, NJ
12 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Clifton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Menerima pesertaFase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Menerima pesertaFase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi jauhnya
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Menerima pesertaFase 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi jauhnya
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi jauhnya
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Menerima pesertaFase 2
- Hackensack Meridian Health, Hackensack · 7 mi jauhnya
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Menerima pesertaFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Menerima pesertaFase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi jauhnya
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Menerima pesertaFase 3
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Menerima pesertaFase 1
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Menerima pesertaStudi observasional
- John Theurer Cancer Center, Hackensack · 7 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Clifton
- Kanker Paru Non-Sel Kecil24 studi
- Kanker (semua jenis)15 studi
- Mieloma Multipel14 studi
- Kanker Metastatik12 studi
- Leukemia Mieloid Akut12 studi
- Kanker Prostat12 studi
- Kanker Ovarium11 studi
- Kanker Paru10 studi
- Kanker Kolorektal8 studi
- Karsinoma Sel Skuamosa Kepala dan Leher8 studi
- Kanker Endometrium8 studi
- Gagal Jantung8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.